✦ LIBER ✦

Longitudinal FEV1 dose–response model for inhaled PF-00610355 and salmeterol in patients with chronic obstructive pulmonary disease

✍ Scribed by Jace C. Nielsen, Matthew M. Hutmacher, Adriaan Cleton, Steven W. Martin, Jakob Ribbing

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Systemic and bronchodilator effects of i

✍ Christopher I. Whale; Milind P. Sovani; Kevin J. Mortimer; Timothy W. Harrison; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 605 KB

Alveolar-capillary membrane permeability

✍ S.-H. Chou; Y.-W. Chen; H.-Y. Chuang; E.-L. Kao; M.-F. Huang 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Efficacy, tolerability, and effects on q

✍ Gabriele Di Lorenzo; Giuseppina Morici; Agata Drago; Maria Esposito Pellitteri; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 890 KB

Effect of Budesonide/Formoterol Pressuri

✍ Ahmad, F.; Zangrilli, J.G.; Martin, U.J. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Does high dose ipratropium bromide added

✍ Koutsogiannis, Z. ;Kelly, A.-M. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB

PDB20 A PHARMACOECONOMIC MODEL FOR ADJUV

✍ M Kayadibinli; B Durguner; P Ulus; B Ozdemir 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB